Replies to post #188425 on Biotech Values

[DewDiligence]

I would bet money (at even odds) that Ackman’s new 4.9% stake in VRX is part of an undisclosed side deal from their (failed) joint attempt to acquire AGN:

http://www.marketwatch.com/story/valeant-shares-up-28-as-pershing-discloses-49-stake-2015-03-09